| http://www.w3.org/ns/prov#value | - These observations allowed progression to the phase Ib trial(1220.2) reported here.Patients and methodsStudy designThis was a randomized, multi-center, multiple rising-dose trial, performedbetween December 2007 and June 2008 at 16 sites in France, Germany, Spain,and USA. The trial was double-blind and placebo-controlled for groups with treat-ment-na??ve (TN) patients.
|
